TiGenix
The AstraZeneca Competition Case: Patent Strategies Constituting Abuse of Dominance

On 6 December 2012, the Court of Justice of the European Union affirmed that AstraZeneca abused its dominant position by engaging in certain intellectual property strategies aimed at protecting its...Read more

Bart Goddyn
Senior Legal Counsel, TiGenix , Belgium